252 related articles for article (PubMed ID: 31434946)
21. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
[TBL] [Abstract][Full Text] [Related]
22. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
24. Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation.
Wen SY; Tsai CY; Pai PY; Chen YW; Yang YC; Aneja R; Huang CY; Kuo WW
Environ Toxicol; 2018 Jan; 33(1):93-103. PubMed ID: 29087013
[TBL] [Abstract][Full Text] [Related]
25. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
[TBL] [Abstract][Full Text] [Related]
29. Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin.
Lee BS; Oh J; Kang SK; Park S; Lee SH; Choi D; Chung JH; Chung YW; Kang SM
PLoS One; 2015; 10(8):e0135438. PubMed ID: 26271039
[TBL] [Abstract][Full Text] [Related]
30. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.
Venkatakrishnan CD; Dunsmore K; Wong H; Roy S; Sen CK; Wani A; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1736-44. PubMed ID: 18263706
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.
Kobayashi S; Volden P; Timm D; Mao K; Xu X; Liang Q
J Biol Chem; 2010 Jan; 285(1):793-804. PubMed ID: 19901028
[TBL] [Abstract][Full Text] [Related]
32. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
[TBL] [Abstract][Full Text] [Related]
33. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
[TBL] [Abstract][Full Text] [Related]
34. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
35. CO and bilirubin inhibit doxorubicin-induced cardiac cell death.
Kim DS; Chae SW; Kim HR; Chae HJ
Immunopharmacol Immunotoxicol; 2009; 31(1):64-70. PubMed ID: 18756386
[TBL] [Abstract][Full Text] [Related]
36. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
37. Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice.
Hsu PL; Mo FE
Oncotarget; 2016 Jun; 7(24):36698-36710. PubMed ID: 27167338
[TBL] [Abstract][Full Text] [Related]
38. Apocynum venetum leaf extract alleviated doxorubicin-induced cardiotoxicity through the AKT/Bcl-2 signaling pathway.
Zhang Y; Liu S; Ma JL; Chen C; Huang P; Ji JH; Wu D; Ren LQ
Phytomedicine; 2022 Jan; 94():153815. PubMed ID: 34781232
[TBL] [Abstract][Full Text] [Related]
39. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.
Ludke A; Sharma AK; Bagchi AK; Singal PK
Mol Cell Biochem; 2012 Jan; 360(1-2):215-24. PubMed ID: 21938406
[TBL] [Abstract][Full Text] [Related]
40. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
